Cambridge Healthtech Institute’s 3rd Annual

Immuno-Oncology Biomarkers 2: Predictive Biomarkers and Companion Diagnostics

August 28-29, 2018

As pharmaceutical and biotechnology companies increase their investment in immuno-oncology programs to facilitate rapid development of novel immunotherapies, there is increasing pressure to discover and validate relevant biomarkers. Cambridge Healthtech Institute’s Third Annual Immuno-Oncology Biomarkers 2: Predictive Biomarkers and Companion Diagnostics meeting will bring together biomarkers experts from industry and academia to address rapid development of predictive and prognostic IO biomarkers, utility of these biomarkers in clinical trials, and their potential as companion diagnostics.

Coverage will include, but is not limited to:

  • Integrative biomarker analysis from immunology, oncology and “omics” data
  • Immune-based biomarkers to predict clinical response
  • Profiling of tumor infiltrating immune cells
  • Microsatellite instability and mismatch repair deficiency biomarkers
  • Biology of tumor microenvironment
  • PD-L1 as a predictive biomarker and companion diagnostic
  • Mechanism of non-response: resistance or lack of efficacy
  • Development of companion diagnostics assays
  • Regulatory considerations in IO biomarker development

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for priority consideration is February 9, 2018.

All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For more details on the conference, please contact:
Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute

For partnering and sponsorship information, please contact:
Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
Phone: (+1) 781-247-6286